Abstract
Radiofrequency ablation is a minimally invasive procedure alternative to surgery to treat benign thyroid nodules causing compressive symptoms. Tolerability of this procedure, aimed at treatment of benign conditions, is fundamental. In this study, we evaluated if local anesthesia should be enough to reduce both hospital costs and sedation-related risks for the patient, avoiding deep sedation and presence of the anesthesiologist. From July 2017 to August 2018, 14 consecutive patients (mean age 60.1 years) were treated and divided in two groups: Group A (7 patients) underwent systemic sedoanalgesia (intravenous remifentanil/fentanyl ± intravenous midazolam ± intravenous acetaminophen/nonsteroidal anti-inflammatory drugs) + subcutaneous anesthesia (lidocaine), with anesthesiologist. Group B (7 patients) underwent mild systemic sedoanalgesia (oral solution morphine sulfate + intravenous midazolam + intravenous acetaminophen) + both subcutaneous and subcapsular anesthesia (mepivacaine + bupivacaine), without anesthesiologist. Tolerability, sedation grade (Ramsay scale), total opioid dose, complications, and results at 12 months were analyzed and compared. Mean tolerability was 9.4 in group A and 8.9 in group B (p: 0.786). Mean sedation grade was 3.86 in group A and 2.71 in group B (p: 0.016). Mean total opioid dose was 70.9 mg in group A and 10 mg in group B (p:0.00015). No complications were observed. At 12 months, mean volume reduction was 56.1% in the group A and 60% in the group B. In thyroid radiofrequency ablation, subcapsular anesthesia can decrease both total opioid dose and level of patient’s sedation without significant differences in tolerability, allowing to perform ablation without the anesthesiologist.
Similar content being viewed by others
References
Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am. 2007;36(3):707–35.
Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, et al. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab. 2013;98(2):564–70.
Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, et al. The natural history of benign thyroid nodules. JAMA. 2015;313(9):926–354.
Nakamura H, Hirokawa M, Ota H, Kihara M, Miya A, Miyauchi A. Is an increase in thyroid nodule volume a risk factor for malignancy? Thyroid. 2015;25(7):804–11.
Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ, Lee D, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244–50.
Moalem J, Suh I, Duh QY. Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature. World J Surg. 2008;32(7):1301–12.
Serpell JW, Phan D. Safety of total thyroidectomy. ANZ J Surg. 2007;77(1–2):15–9.
Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, et al. Complications of thyroid surgery: analysis of a multicentric study on 14934 patients operated on in Italy over 5 years. World J Surg. 2004;28(3):271–6.
Afolabi AO, Ayandipo OO, Afuwape OO. A fifteen year experience of total thyroidectomy for the management of simple multinodular goitres in a low medium income Country. S Afr J Surg. 2016;54(4):40–5.
Bergenfelz A, Jansson S, Kristoffersson A, Mårtensson H, Reihnér E, Wallin G, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg. 2008;393(5):667–73.
Kim YJ, Baek JH, Ha EJ, Lim HK, Lee JH, Sung JY, et al. Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors. Eur Radiol. 2012;22(7):1573–8.
Sui WF, Li JY, Fu JH. Percutaneous laser ablation for benign thyroid nodules: a meta-analysis. Oncotarget. 2017;8(47):83225–36.
De Bernardi IC, Floridi C, Muollo A, Giacchero R, Dionigi GL, Reginelli A, et al. Vascular and interventional radiology radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: literature review. Radiol Med. 2014;119(7):512–20.
Pompili G, Borelli A, Panella S, Masu A, et al. Microwave ablation for thyroid nodules: a new string to the bow for percutaneous treatments? Gland Surg. 2016;5(6):553–8.
Lang BH, Wu ALH. The efficacy and safety of high-intensity focused ultrasound ablation of benign thyroid nodules. Ultrasonography. 2018;37(2):89–97.
Jung SL, Baek JH, Lee JH, Shong YK, Sung JY, Kim KS, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol. 2018;19(1):167–74.
Baek JH, Lee JH, Sung JY, Bae JI, Kim KT, Sim J, et al. Complications encountered in the treatment of benign thyroid nodules with us-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262(1):335–42.
Deandrea M, Trimboli P, Garino F, Mormile A, Magliona G, Ramunni MJ, et al. Long term efficacy of a single session rfa of benign thyroid nodules: a longitudinal 5-year observational study. J Clin Endocrinol Metab. 2019;104:3751–6.
Deandrea M, Garino F, Alberto M, Garberoglio R, Rossetto R, Bonelli N, et al. Radiofrequency ablation for benign thyroid nodules according to different ultrasound features: an Italian multicentre prospective study. Eur J Endocrinol. 2019;180(1):79–877.
Zhang B, Moser M, Zhang E, Zhang WJ. Radiofrequency ablation technique in the treatment of liver tumours: review and future issues. J Med Eng Technol. 2013;37(2):150–9.
Wagstaff P, Ingels A, Zondervan P, de la Rosette JJ, Laguna MP. Thermal ablation in renal cell carcinoma management: a comprehensive review. Curr Opin Urol. 2014;24(5):474–82.
Alexander ES, Dupuy DE. Lung cancer ablation: technologies and techniques. Semin Intervent Radiol. 2013;30(2):141–50.
Nardi F, Basolo F, Crescenzi A, Fadda G, Frasoldati A, Orlandi F, et al. Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Invest. 2014;37(6):593–9.
Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol. 2011;12:525–40.
Morelli F, Ierardi AM, Pompili G, Sacrini A, Biondetti P, Angileri SA, et al. Cooled tip radiofrequency ablation of benign thyroid nodules: preliminary experience with two different devices. Gland Surg. 2018;7(2):67–79.
Ramsay MAE, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alpaxalone-alphadolone. BMJ. 1974;2:656–9.
Patanwala AE, Duby J, Waters D, Erstad BL. Opioid conversions in acute care. Ann Pharmacother. 2007;41(2):255–66.
Ashburn MA, Lipman AG. Principles of analgesic use in the treatment of acute pain and chronic cancer pain. 5th ed. Glenview, IL: American Pain Society; 2003.
Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, editor. Goodman & Gillman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw Hill; 2001. p. 569–661.
The National Cancer Institute (2010) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Bethesda. Approved after October 1, 2009.
Bernardi S, Dobrinja C, Carere A, Giudici F, Calabrò V, Zanconati F, et al. Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey. Int J Hyperthermia. 2018;15:1–9.
Bernardi S, Dobrinja C, Fabris B, Bazzocchi G, Sabato N, Ulcigrai V, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol. 2014;2014:934595.
Wang JF, Wu T, Hu KP, Xu W, Zheng BW, Tong G, et al. Complications following radiofrequency ablation of benign thyroid nodules: a systematic review. Chin Med J. 2017;130(11):1361–70.
Kelly EF, Leveillee RJ. Image guided radiofrequency ablation for small renal masses. Int J Surg. 2016;36(Pt C):525–32.
de Boer HD, Detriche O, Forget P. Opioid-related side effects: postoperative ileus, urinary retention, nausea and vomiting, and shivering. A review of the literature. Best Pract Res Clin Anaesthesiol. 2017;31(4):499–504.
Funding
This study was not supported by any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was also approved by our Institutional Review Board (“gruppo di studio endocrinologico dell’Ospedale San Paolo”; protocol number: 2017-T435).
Informed consent
Consent for publication was obtained for every individual person’s data included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Morelli, F., Ierardi, A.M., Biondetti, P. et al. The importance of subcapsular anesthesia in the anesthesiological management for thyroid radiofrequency ablation. Med Oncol 37, 22 (2020). https://doi.org/10.1007/s12032-020-01347-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-020-01347-z